NCT06081894Phase 3Active not recruiting

A Trial to Evaluate the Efficacy and Safety of Aficamten Compared to Placebo in Adults With Symptomatic Non-Obstructive Hypertrophic Cardiomyopathy (nHCM)

Study sponsor: Cytokinetics

Primary completion is the date data collection ends for the main study measures, not when results are published.

Primary completion2026-08-31Actual
Enrollment · participants500Estimated
Source updated2026-09-22Last update listed in the registry record

Changes to this trial

Last 12 months
Filters
Clear filters

· 2 fields changed

Completion date type changed

Before: Estimated. After: Actual.

Primary completion date changed

Before: Aug 2026. After: 31 Aug 2026.

Check registry source

· 1 field changed

Primary completion date changed

Before: Jun 2026. After: Aug 2026.

Check registry source

Explore older trial changes

Upgrade to Pro to see the full available history for this trial.

Upgrade to Pro Illustrative preview